Dec 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including HCA Healthcare, Ncino and Progyny, on Monday.
HIGHLIGHTS
* HCA Healthcare Inc : JP Morgan raises target price to $380
from $379
* Ncino Inc : KBW raises target price to $49 from $41
* Progyny Inc : JP Morgan cuts to neutral from overweight
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* Ardent Health Partners Inc : JP Morgan raises target price to
$20 from $19
* HCA Healthcare Inc : JP Morgan raises target price to $380 from
$379
* Ncino Inc : KBW raises target price to $49 from $41
* Progyny Inc : JP Morgan cuts target price to $17 from $22
* Progyny Inc : JP Morgan cuts to neutral from overweight
* Tenet Healthcare Corp : JP Morgan raises target price to $175
from $172
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。